 Neutrophils high affinity receptor IgG Fc gamma RI vivo application recombinant human granulocyte colony-stimulating factor Fc receptors important effector molecules neutrophilic granulocytes polymorphonuclear neutrophils PMN phagocytic cells specific immune response healthy donors low-affinity receptors IgG Fc gamma RII Fc gamma RIII high-affinity receptor Fc gamma RI latter neutrophils patients certain bacterial infections vitro incubation interferon-gamma express Fc gamma RI vivo application recombinant human granulocyte colony-stimulating factor rhG-CSF patients rhG-CSF displayed cytotoxicity Daudi lymphoma cells vitro control patients healthy donors Fab fragments Fc gamma RII monoclonal antibody MoAb neutrophil-mediated cytotoxicity healthy donors patients rhG-CSF therapy expression Fc receptors PMN flow cytometry mean fluorescence intensity MFI MoAb Fc gamma RL median MFI neutrophils G-CSF patients median range median MFI patients G-CSF median range median MFI healthy donors median range Fc gamma RI discontinuing G-CSF injections next treatment cycle rhG-CSF high expression Fc gamma RI rhG-CSF therapy enhanced cytotoxicity vitro incubation rhG-CSF cytotoxicity minor increments Fc gamma RI expression vivo application rhG-CSF neutrophils additional potent receptor tumor cell vitro induction high-affinity receptor IgG Fc gamma RI